List of Tables
Table 1. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bacterial Enteric Disease Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bacterial Enteric Disease Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Bacterial Enteric Disease Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Bacterial Enteric Disease Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Bacterial Enteric Disease Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Enteric Disease Testing as of 2024)
Table 11. Global Bacterial Enteric Disease Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Bacterial Enteric Disease Testing Companies Headquarters
Table 13. Global Bacterial Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Bacterial Enteric Disease Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Bacterial Enteric Disease Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Bacterial Enteric Disease Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Bacterial Enteric Disease Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Bacterial Enteric Disease Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Bacterial Enteric Disease Testing Growth Accelerators and Market Barriers
Table 25. North America Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Bacterial Enteric Disease Testing Growth Accelerators and Market Barriers
Table 27. Europe Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Bacterial Enteric Disease Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Bacterial Enteric Disease Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Bacterial Enteric Disease Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Becton Dickinson & Company Corporation Information
Table 35. Becton Dickinson & Company Description and Major Businesses
Table 36. Becton Dickinson & Company Product Features and Attributes
Table 37. Becton Dickinson & Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Becton Dickinson & Company Revenue Proportion by Product in 2024
Table 39. Becton Dickinson & Company Revenue Proportion by Application in 2024
Table 40. Becton Dickinson & Company Revenue Proportion by Geographic Area in 2024
Table 41. Becton Dickinson & Company Bacterial Enteric Disease Testing SWOT Analysis
Table 42. Becton Dickinson & Company Recent Developments
Table 43. Bio-Rad Laboratories, Inc Corporation Information
Table 44. Bio-Rad Laboratories, Inc Description and Major Businesses
Table 45. Bio-Rad Laboratories, Inc Product Features and Attributes
Table 46. Bio-Rad Laboratories, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bio-Rad Laboratories, Inc Revenue Proportion by Product in 2024
Table 48. Bio-Rad Laboratories, Inc Revenue Proportion by Application in 2024
Table 49. Bio-Rad Laboratories, Inc Revenue Proportion by Geographic Area in 2024
Table 50. Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing SWOT Analysis
Table 51. Bio-Rad Laboratories, Inc Recent Developments
Table 52. Biomerieux SA Corporation Information
Table 53. Biomerieux SA Description and Major Businesses
Table 54. Biomerieux SA Product Features and Attributes
Table 55. Biomerieux SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Biomerieux SA Revenue Proportion by Product in 2024
Table 57. Biomerieux SA Revenue Proportion by Application in 2024
Table 58. Biomerieux SA Revenue Proportion by Geographic Area in 2024
Table 59. Biomerieux SA Bacterial Enteric Disease Testing SWOT Analysis
Table 60. Biomerieux SA Recent Developments
Table 61. Quest Diagnostics Inc Corporation Information
Table 62. Quest Diagnostics Inc Description and Major Businesses
Table 63. Quest Diagnostics Inc Product Features and Attributes
Table 64. Quest Diagnostics Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Quest Diagnostics Inc Revenue Proportion by Product in 2024
Table 66. Quest Diagnostics Inc Revenue Proportion by Application in 2024
Table 67. Quest Diagnostics Inc Revenue Proportion by Geographic Area in 2024
Table 68. Quest Diagnostics Inc Bacterial Enteric Disease Testing SWOT Analysis
Table 69. Quest Diagnostics Inc Recent Developments
Table 70. Diasorin S.p.A. Corporation Information
Table 71. Diasorin S.p.A. Description and Major Businesses
Table 72. Diasorin S.p.A. Product Features and Attributes
Table 73. Diasorin S.p.A. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Diasorin S.p.A. Revenue Proportion by Product in 2024
Table 75. Diasorin S.p.A. Revenue Proportion by Application in 2024
Table 76. Diasorin S.p.A. Revenue Proportion by Geographic Area in 2024
Table 77. Diasorin S.p.A. Bacterial Enteric Disease Testing SWOT Analysis
Table 78. Diasorin S.p.A. Recent Developments
Table 79. Meridian Bioscience Inc Corporation Information
Table 80. Meridian Bioscience Inc Description and Major Businesses
Table 81. Meridian Bioscience Inc Product Features and Attributes
Table 82. Meridian Bioscience Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Meridian Bioscience Inc Recent Developments
Table 84. Abbott Laboratories Corporation Information
Table 85. Abbott Laboratories Description and Major Businesses
Table 86. Abbott Laboratories Product Features and Attributes
Table 87. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Recent Developments
Table 89. Trinity Biotech Corporation Information
Table 90. Trinity Biotech Description and Major Businesses
Table 91. Trinity Biotech Product Features and Attributes
Table 92. Trinity Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Trinity Biotech Recent Developments
Table 94. Coris BioConcept Corporation Information
Table 95. Coris BioConcept Description and Major Businesses
Table 96. Coris BioConcept Product Features and Attributes
Table 97. Coris BioConcept Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Coris BioConcept Recent Developments
Table 99. Biomerica, Inc. Corporation Information
Table 100. Biomerica, Inc. Description and Major Businesses
Table 101. Biomerica, Inc. Product Features and Attributes
Table 102. Biomerica, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Biomerica, Inc. Recent Developments
Table 104. Cepheid Corporation Information
Table 105. Cepheid Description and Major Businesses
Table 106. Cepheid Product Features and Attributes
Table 107. Cepheid Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Cepheid Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Bacterial Enteric Disease Testing Product Picture
Figure 2. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Reagents and Consumables Product Picture
Figure 4. Equipment Product Picture
Figure 5. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Academic and Research Institutes
Figure 7. Hospital Laboratories
Figure 8. Pharmaceutical and Biotechnology Companies
Figure 9. Bacterial Enteric Disease Testing Report Years Considered
Figure 10. Global Bacterial Enteric Disease Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 12. Global Bacterial Enteric Disease Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Bacterial Enteric Disease Testing Revenue Market Share by Region (2020-2031)
Figure 14. Global Bacterial Enteric Disease Testing Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Reagents and Consumables Revenue Market Share by Player in 2024
Figure 17. Equipment Revenue Market Share by Player in 2024
Figure 18. Global Bacterial Enteric Disease Testing Revenue Market Share by Type (2020-2031)
Figure 19. Global Bacterial Enteric Disease Testing Revenue Market Share by Application (2020-2031)
Figure 20. North America Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 22. North America Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 29. Europe Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 32. France Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 44. India Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 52. Central and South America Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 58. South America Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 64. Bacterial Enteric Disease Testing Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
